niacinamide has been researched along with Affective Disorders in 3 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
Excerpt | Relevance | Reference |
---|---|---|
"Niaprazine is a histamine H1-receptor antagonist with marked sedative properties." | 5.30 | Niaprazine in the treatment of autistic disorder. ( D'Agata, M; Parmeggiani, A; Pipitone, E; Posar, A; Rossi, PG, 1999) |
"Fifty patients with tension headache, aged from 18 to 50 years, were studied." | 2.90 | [Possibilities of using Cytoflavin in the treatment of cognitive and emotional disorders in patients with tension headaches]. ( Chutko, LS; Majidova, EN; Rozhkova, AV; Surushkina, SY; Volov, MB; Yakovenko, EA; Zhukovskaya, NV, 2019) |
"Niaprazine is a histamine H1-receptor antagonist with marked sedative properties." | 1.30 | Niaprazine in the treatment of autistic disorder. ( D'Agata, M; Parmeggiani, A; Pipitone, E; Posar, A; Rossi, PG, 1999) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chutko, LS | 1 |
Surushkina, SY | 1 |
Yakovenko, EA | 1 |
Rozhkova, AV | 1 |
Volov, MB | 1 |
Zhukovskaya, NV | 1 |
Majidova, EN | 1 |
Brandi, G | 1 |
de Rosa, F | 1 |
Calzà, L | 1 |
Girolamo, SD | 1 |
Tufoni, M | 1 |
Ricci, CS | 1 |
Cirignotta, F | 1 |
Caraceni, P | 1 |
Biasco, G | 1 |
Rossi, PG | 1 |
Posar, A | 1 |
Parmeggiani, A | 1 |
Pipitone, E | 1 |
D'Agata, M | 1 |
1 trial available for niacinamide and Affective Disorders
Article | Year |
---|---|
[Possibilities of using Cytoflavin in the treatment of cognitive and emotional disorders in patients with tension headaches].
Topics: Adolescent; Adult; Anxiety; Cognition; Drug Combinations; Flavin Mononucleotide; Humans; Inosine Dip | 2019 |
2 other studies available for niacinamide and Affective Disorders
Article | Year |
---|---|
Can the tyrosine kinase inhibitors trigger metabolic encephalopathy in cirrhotic patients?
Topics: Aged; Brain Diseases, Metabolic; Carcinoma, Hepatocellular; Cognition Disorders; Electroencephalogra | 2013 |
Niaprazine in the treatment of autistic disorder.
Topics: Adolescent; Adult; Aggression; Attention Deficit Disorder with Hyperactivity; Autistic Disorder; Chi | 1999 |